These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 34924383)

  • 1. Studying APOE ɛ4 Allele Dose Effects with a Univariate Morphometry Biomarker.
    Wang G; Zhou W; Kong D; Qu Z; Ba M; Hao J; Yao T; Dong Q; Su Y; Reiman EM; Caselli RJ; Chen K; Wang Y;
    J Alzheimers Dis; 2022; 85(3):1233-1250. PubMed ID: 34924383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Apolipoprotein E ɛ4 Allele With Clinical and Multimodal Biomarker Changes of Alzheimer Disease in Adults With Down Syndrome.
    Bejanin A; Iulita MF; Vilaplana E; Carmona-Iragui M; Benejam B; Videla L; Barroeta I; Fernandez S; Altuna M; Pegueroles J; Montal V; Valldeneu S; Giménez S; González-Ortiz S; Muñoz L; Padilla C; Aranha MR; Estellés T; Illán-Gala I; Belbin O; Camacho V; Wilson LR; Annus T; Osorio RS; Videla S; Lehmann S; Holland AJ; Zetterberg H; Blennow K; Alcolea D; Clarimon J; Zaman SH; Blesa R; Lleó A; Fortea J
    JAMA Neurol; 2021 Aug; 78(8):937-947. PubMed ID: 34228042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Developing univariate neurodegeneration biomarkers with low-rank and sparse subspace decomposition.
    Wang G; Dong Q; Wu J; Su Y; Chen K; Su Q; Zhang X; Hao J; Yao T; Liu L; Zhang C; Caselli RJ; Reiman EM; Wang Y;
    Med Image Anal; 2021 Jan; 67():101877. PubMed ID: 33166772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Applying surface-based hippocampal morphometry to study APOE-E4 allele dose effects in cognitively unimpaired subjects.
    Dong Q; Zhang W; Wu J; Li B; Schron EH; McMahon T; Shi J; Gutman BA; Chen K; Baxter LC; Thompson PM; Reiman EM; Caselli RJ; Wang Y
    Neuroimage Clin; 2019; 22():101744. PubMed ID: 30852398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Multi-Cohort Study of ApoE ɛ4 and Amyloid-β Effects on the Hippocampus in Alzheimer's Disease.
    Khan W; Giampietro V; Banaschewski T; Barker GJ; Bokde AL; Büchel C; Conrod P; Flor H; Frouin V; Garavan H; Gowland P; Heinz A; Ittermann B; Lemaître H; Nees F; Paus T; Pausova Z; Rietschel M; Smolka MN; Ströhle A; Gallinat J; Vellas B; Soininen H; Kloszewska I; Tsolaki M; Mecocci P; Spenger C; Villemagne VL; Masters CL; Muehlboeck JS; Bäckman L; Fratiglioni L; Kalpouzos G; Wahlund LO; Schumann G; Lovestone S; Williams SC; Westman E; Simmons A; ; ;
    J Alzheimers Dis; 2017; 56(3):1159-1174. PubMed ID: 28157104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of APOE Genotype on Amyloid Deposition, Brain Volume, and Memory in Cognitively Normal Older Individuals.
    Lim YY; Williamson R; Laws SM; Villemagne VL; Bourgeat P; Fowler C; Rainey-Smith S; Salvado O; Martins RN; Rowe CC; Masters CL; Maruff P;
    J Alzheimers Dis; 2017; 58(4):1293-1302. PubMed ID: 28550258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma NfL is associated with the APOE ε4 allele, brain imaging measurements of neurodegeneration, and lower recall memory scores in cognitively unimpaired late-middle-aged and older adults.
    Malek-Ahmadi M; Su Y; Ghisays V; Luo J; Devadas V; Chen Y; Lee W; Protas H; Chen K; Zetterberg H; Blennow K; Caselli RJ; Reiman EM
    Alzheimers Res Ther; 2023 Apr; 15(1):74. PubMed ID: 37038190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Healthy versus Entorhinal Cortical Atrophy Identification in Asymptomatic APOE4 Carriers at Risk for Alzheimer's Disease.
    Konishi K; Joober R; Poirier J; MacDonald K; Chakravarty M; Patel R; Breitner J; Bohbot VD
    J Alzheimers Dis; 2018; 61(4):1493-1507. PubMed ID: 29278888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. APOE ε4 gene dose effect on imaging and blood biomarkers of neuroinflammation and beta-amyloid in cognitively unimpaired elderly.
    Snellman A; Ekblad LL; Tuisku J; Koivumäki M; Ashton NJ; Lantero-Rodriguez J; Karikari TK; Helin S; Bucci M; Löyttyniemi E; Parkkola R; Karrasch M; Schöll M; Zetterberg H; Blennow K; Rinne JO
    Alzheimers Res Ther; 2023 Apr; 15(1):71. PubMed ID: 37016464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The
    Saeed U; Desmarais P; Masellis M
    Expert Rev Neurother; 2021 Aug; 21(8):851-870. PubMed ID: 34311631
    [No Abstract]   [Full Text] [Related]  

  • 11. Association of APOE ɛ4 and Plasma p-tau181 with Preclinical Alzheimer's Disease and Longitudinal Change in Hippocampus Function.
    Salami A; Adolfsson R; Andersson M; Blennow K; Lundquist A; Adolfsson AN; Schöll M; Zetterberg H; Nyberg L
    J Alzheimers Dis; 2022; 85(3):1309-1320. PubMed ID: 34924376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic influence of apolipoprotein E4 genotype on hippocampal morphometry: An N = 725 surface-based Alzheimer's disease neuroimaging initiative study.
    Shi J; Leporé N; Gutman BA; Thompson PM; Baxter LC; Caselli RJ; Wang Y;
    Hum Brain Mapp; 2014 Aug; 35(8):3903-18. PubMed ID: 24453132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of β-Amyloid and Apolipoprotein E ε4 With Memory Decline in Preclinical Alzheimer Disease.
    Lim YY; Kalinowski P; Pietrzak RH; Laws SM; Burnham SC; Ames D; Villemagne VL; Fowler CJ; Rainey-Smith SR; Martins RN; Rowe CC; Masters CL; Maruff PT
    JAMA Neurol; 2018 Apr; 75(4):488-494. PubMed ID: 29356823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longitudinal brain imaging in preclinical Alzheimer disease: impact of APOE ε4 genotype.
    Mishra S; Blazey TM; Holtzman DM; Cruchaga C; Su Y; Morris JC; Benzinger TLS; Gordon BA
    Brain; 2018 Jun; 141(6):1828-1839. PubMed ID: 29672664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain imaging measurements of fibrillar amyloid-β burden, paired helical filament tau burden, and atrophy in cognitively unimpaired persons with two, one, and no copies of the APOE ε4 allele.
    Ghisays V; Goradia DD; Protas H; Bauer RJ; Devadas V; Tariot PN; Lowe VJ; Knopman DS; Petersen RC; Jack CR; Caselli RJ; Su Y; Chen K; Reiman EM
    Alzheimers Dement; 2020 Apr; 16(4):598-609. PubMed ID: 31831374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced Gray Matter Volume of the Thalamus and Hippocampal Region in Elderly Healthy Adults with no Impact of APOE ɛ4: A Longitudinal Voxel-Based Morphometry Study.
    Squarzoni P; Duran FLS; Busatto GF; Alves TCTF
    J Alzheimers Dis; 2018; 62(2):757-771. PubMed ID: 29480170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of apolipoprotein E4-cerebrospinal fluid β-amyloid interaction on hippocampal volume loss over 1 year in mild cognitive impairment.
    Chiang GC; Insel PS; Tosun D; Schuff N; Truran-Sacrey D; Raptentsetsang ST; Thompson PM; Reiman EM; Jack CR; Fox NC; Jagust WJ; Harvey DJ; Beckett LA; Gamst A; Aisen PS; Petersen RC; Weiner MW;
    Alzheimers Dement; 2011 Sep; 7(5):514-20. PubMed ID: 21889115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of APOE Genotype on Hippocampal Atrophy over Time - An N=1925 Surface-Based ADNI Study.
    Li B; Shi J; Gutman BA; Baxter LC; Thompson PM; Caselli RJ; Wang Y;
    PLoS One; 2016; 11(4):e0152901. PubMed ID: 27065111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 18F-AV45 PET and MRI Reveal the Influencing Factors of Alzheimer's Disease Biomarkers in Subjective Cognitive Decline Population.
    Zhao Z; Wang J; Wang Y; Liu X; He K; Guo Q; Xie F; Huang Q; Li Z
    J Alzheimers Dis; 2023; 93(2):585-594. PubMed ID: 37066915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Associations Between Sub-Threshold Amyloid-β Deposition, Cortical Volume, and Cognitive Function Modulated by APOE ɛ4 Carrier Status in Cognitively Normal Older Adults.
    Kang DW; Wang SM; Um YH; Kim NY; Lee CU; Lim HK
    J Alzheimers Dis; 2022; 89(3):1003-1016. PubMed ID: 35964194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.